9,491
Views
7
CrossRef citations to date
0
Altmetric
Review Articles

Rotavirus-related systemic diseases: clinical manifestation, evidence and pathogenesis

, , , , , , , & ORCID Icon show all
Pages 580-595 | Received 07 Nov 2020, Accepted 16 Mar 2021, Published online: 06 Apr 2021

Figures & data

Figure 1. Rotavirus infection-induced acute gastroenteritis. The rotavirus particle contains 11 segments of dsRNA as its genome, and the capsid consists of three layers. The intestinal epithelium is characterized by the villi and crypt. Mature enterocytes locate at the top and middle of villi allow SGLT-1-mediated absorption of water and salt. The ECs locate at the middle of villi are highly specialized cells with endocrine function. Stem cells and Paneth cells locate in the crypt are functionally responsible for differentiation and secretion, respectively. Thus, under normal conditions, the intact intestinal membrane barrier can keep homeostasis (absorption and secretion). While rotavirus infection in mature enterocytes causes absorptive enterocyte death and secretory Paneth cell replacement, leading to shortening and blunting of villi, and increasing infiltration of inflammatory cells in the lamina propria. The NSP4 stimulates the epithelium and ECs to increase intracellular calcium, which further induces the secretion of 5-HT from ECs through a calcium-dependent manner. The secreted 5-HT activates EGCs to increase release of GDNF which induces the expression of tight junction-associated protein ZO-1 in infected and bystander cells. Thus neurotrophic factors and 5-HT can protect the intestinal barrier function during rotavirus insult. Moreover, the number of enterocytes remaining following infection is functionally sufficient to allow SGLT-1-mediated absorption of water and salt. However, 5-HT can also activate the intrinsic primary afferent nerves of the myenteric plexus. Such activation activates the nerves of the submucosal plexus and leads to increase of intestinal motility which can be attenuated by an opioid-receptor-antagonist (Loperamide). The activation of submucosal nerves further induce VIP release from nerve endings adjacent to crypt cells. Then, VIP induces crypt cells to secret NaCl and water into the intestinal lumen by increasing cellular cAMP levels, which ultimately leading to secretory diarrhoea. During these processes, the stimulated afferent vagal signalling activates the nausea and vomiting centre of the brain to generate efferent vagal signalling which then results in vomiting by stimulating a nerve-muscle vomiting reflex in the stomach. This event can be attenuated by 5-HT receptor antagonists (Ondansetron). Finally, intestinal rotavirus infection results in secretory-driven watery diarrhoea accompanying by vomiting. dsRNA: double-stranded RNA; VPs: rotavirus structural proteins (VP4 is cleaved into VP5* and VP8*); NSP4: rotavirus non-structural protein; ENS: enteric nervous system; NaCl: sodium chloride; Ca2+: calcium ions; SGLT-1: sodium/glucose cotransporter 1; 5-HT: 5-hydroxytryptamine (serotonin); VIP: vasoactive intestinal peptide; ECs: enterochromaffin cells; EGCs: enteric glial cells; GDNF: glial cell-derived neurotrophic factor; ZO-1: zona occludens 1; cAMP: cyclic adenosine monophosphate.

Figure 1. Rotavirus infection-induced acute gastroenteritis. The rotavirus particle contains 11 segments of dsRNA as its genome, and the capsid consists of three layers. The intestinal epithelium is characterized by the villi and crypt. Mature enterocytes locate at the top and middle of villi allow SGLT-1-mediated absorption of water and salt. The ECs locate at the middle of villi are highly specialized cells with endocrine function. Stem cells and Paneth cells locate in the crypt are functionally responsible for differentiation and secretion, respectively. Thus, under normal conditions, the intact intestinal membrane barrier can keep homeostasis (absorption and secretion). While rotavirus infection in mature enterocytes causes absorptive enterocyte death and secretory Paneth cell replacement, leading to shortening and blunting of villi, and increasing infiltration of inflammatory cells in the lamina propria. The NSP4 stimulates the epithelium and ECs to increase intracellular calcium, which further induces the secretion of 5-HT from ECs through a calcium-dependent manner. The secreted 5-HT activates EGCs to increase release of GDNF which induces the expression of tight junction-associated protein ZO-1 in infected and bystander cells. Thus neurotrophic factors and 5-HT can protect the intestinal barrier function during rotavirus insult. Moreover, the number of enterocytes remaining following infection is functionally sufficient to allow SGLT-1-mediated absorption of water and salt. However, 5-HT can also activate the intrinsic primary afferent nerves of the myenteric plexus. Such activation activates the nerves of the submucosal plexus and leads to increase of intestinal motility which can be attenuated by an opioid-receptor-antagonist (Loperamide). The activation of submucosal nerves further induce VIP release from nerve endings adjacent to crypt cells. Then, VIP induces crypt cells to secret NaCl and water into the intestinal lumen by increasing cellular cAMP levels, which ultimately leading to secretory diarrhoea. During these processes, the stimulated afferent vagal signalling activates the nausea and vomiting centre of the brain to generate efferent vagal signalling which then results in vomiting by stimulating a nerve-muscle vomiting reflex in the stomach. This event can be attenuated by 5-HT receptor antagonists (Ondansetron). Finally, intestinal rotavirus infection results in secretory-driven watery diarrhoea accompanying by vomiting. dsRNA: double-stranded RNA; VPs: rotavirus structural proteins (VP4 is cleaved into VP5* and VP8*); NSP4: rotavirus non-structural protein; ENS: enteric nervous system; NaCl: sodium chloride; Ca2+: calcium ions; SGLT-1: sodium/glucose cotransporter 1; 5-HT: 5-hydroxytryptamine (serotonin); VIP: vasoactive intestinal peptide; ECs: enterochromaffin cells; EGCs: enteric glial cells; GDNF: glial cell-derived neurotrophic factor; ZO-1: zona occludens 1; cAMP: cyclic adenosine monophosphate.

Figure 2. Rotavirus-related systemic diseases and proposed mechanisms. The primary infection of rotavirus in the intestine leads to acute gastroenteritis. However, the tropism and pathogenetic role of rotavirus infection is not only limited to the gastrointestinal tract. The extra-intestinal dissemination and infection of rotavirus in non-intestinal tissues such as the spleen, liver, heart, lung, kidney, testis, bladder, adrenal gland, pancreas and brain have been confirmed, which may sometimes lead to additional extra-intestinal complications. Here we present rotavirus-induced acute gastroenteritis and the frequently reported complications related to rotavirus extra-intestinal spread and propose the potential mechanisms. RV: rotavirus; VP7: viral structural protein; NSP4: non-structural protein; ENS: enteric nervous system; NO: nitric oxide; IFN-γ: interferon gamma.

Figure 2. Rotavirus-related systemic diseases and proposed mechanisms. The primary infection of rotavirus in the intestine leads to acute gastroenteritis. However, the tropism and pathogenetic role of rotavirus infection is not only limited to the gastrointestinal tract. The extra-intestinal dissemination and infection of rotavirus in non-intestinal tissues such as the spleen, liver, heart, lung, kidney, testis, bladder, adrenal gland, pancreas and brain have been confirmed, which may sometimes lead to additional extra-intestinal complications. Here we present rotavirus-induced acute gastroenteritis and the frequently reported complications related to rotavirus extra-intestinal spread and propose the potential mechanisms. RV: rotavirus; VP7: viral structural protein; NSP4: non-structural protein; ENS: enteric nervous system; NO: nitric oxide; IFN-γ: interferon gamma.

Table 1. Clinical manifestation and evidence summary of rotavirus-related systemic diseases.